Topic summary

Personal import allowances, compared

Access › International EMA MHRA telehealth personal import NHS Wiki

This is a generated summary. It shows the 5 most-liked posts from a topic of 10, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

NardoneTL2Member17 Dec 2025#2

Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not eliminate) risk.

3 likes 7mo

n.kaufmannTL2 Moderator18 Dec 2025#3

Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when in doubt.

11 likes 7mo

a.kwiatkowskiTL2Member18 Dec 2025#4

n.kaufmann, post #3: Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when in doubt. Go to post

On post #2 — agreed on the reasoning, with one qualification.

Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.

23 likes in reply to #3 7mo

methods_marginTL3Regular21 Dec 2025#8

IRenaudin, post #6: Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is unclear. Go to post

Worth separating two things that post #4 runs together.

Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more predictive than theory.

3 likes in reply to #6 7mo

crossover_reviewTL3Regular22 Dec 2025#10

Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.

10 likes 7mo

Read the full topic (10 posts)

Suggested topics

Topic	Participants	Replies	Views	Activity
Second pass at: Cross-border purchase within the EU: the actual rules Access › International NHS personal import EMA telehealth Posting this under the heading it deserves: Second pass at: Cross-border purchase within the EU: the actual rules Everything below is what sits behind that. Documenting an access outcome, dated, because…	+135	139	8.7k	16mo
Revisiting: Language barriers in accessing a prescription abroad Access › International EMA telehealth personal import MHRA Posting this under the heading it deserves: Revisiting: Language barriers in accessing a prescription abroad Everything below is what sits behind that. Documenting an access outcome, dated, because everything…	+131	148	28k	5mo
About the International category Access › International personal import EMA MHRA Pinned Wiki Country-by-country availability and legality, dated because it changes constantly. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…	+6	11	240	22mo
Language barriers in accessing a prescription abroad Access › International personal import telehealth EMA Solved Language barriers in accessing a prescription abroad Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this…		2	22k	1h
What changed in 2026, by region Access › International EMA NHS personal import Solved What changed in 2026, by region — that is the question, and I have not found it answered plainly anywhere I have looked. Documenting an access outcome, dated, because everything in this category expires. As…	+110	122	1.4k	18mo

Related topics — sharing the tags EMA, MHRA, telehealth

Topic	Participants	Replies	Views	Activity
Coming back to: Cross-border purchase rules within the EU Regional › European Union EMA cost per milligram personal import Cross-border purchase rules within the EU Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what…	+12	16	2.8k	11mo
Second pass at: When your prescriber and the evidence disagree Clinical › Prescriber conversations beginner friendly type 2 diabetes telehealth prior authorisation Pinned Second pass at: When your prescriber and the evidence disagree — setting out what I have, and where I think it stops being reliable. General question, not a request for advice about my own care — I know the…	+51	55	9.2k	2d
MHRA statements, read directly Regional › UK & Ireland NHS MHRA personal import Solved Pinned MHRA statements, read directly Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what determines the…	+93	101	2.2k	5mo
Second pass at: Import rules for personal quantities, by jurisdiction, dated Sourcing › Regulatory research use only personal import FDA MHRA Second pass at: Import rules for personal quantities, by jurisdiction, dated Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are…		2	5k	11mo
Discussing something you have already been doing — the long version Clinical › Prescriber conversations telehealth prior authorisation beginner friendly type 2 diabetes Solved Discussing something you have already been doing — the long version Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…	+14	18	58k	12mo